financetom
Business
financetom
/
Business
/
Market Chatter: Boeing Seeking to Sell Insitu Reconaissance Drone Unit
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Boeing Seeking to Sell Insitu Reconaissance Drone Unit
Feb 24, 2025 6:24 AM

08:48 AM EST, 02/24/2025 (MT Newswires) -- Boeing ( BA ) is considering a sale of its Insitu unit, which produces small, military-grade long-range surveillance and reconnaissance drones such as the ScanEagle, Bloomberg reported Monday, citing people familiar with the matter.

Insitu, which Boeing ( BA ) acquired in 2008, has drawn interest from private equity firms and other buyers, the report said.

Boeing ( BA ) has already hired an advisor to help it locate a buyer, the report said.

The report cited an expert who valued the company at around $500 million.

Boeing ( BA ) did not immediately reply to MT Newswires' request for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Arch Biopartners Begins Patient Dosing in Canada in Phase II Trial For LSALT Peptide
Arch Biopartners Begins Patient Dosing in Canada in Phase II Trial For LSALT Peptide
Nov 11, 2024
08:03 AM EST, 11/11/2024 (MT Newswires) -- Arch Biopartners ( ACHFF ) says patient recruitment and dosing have begun in Canada for the Phase II trial for LSALT peptide targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI). The clinical team at the University of Calgary has dosed the first patient recruited for the study. The University...
Food Company Aramark Posts Mixed Q4, Increases Dividend By 11% & More
Food Company Aramark Posts Mixed Q4, Increases Dividend By 11% & More
Nov 11, 2024
Aramark ( ARMK ) shares are trading higher after the company reported fourth-quarter results and raised quarterly dividend. Revenue grew 5% year-over-year (Organic revenue: +7%) to $4.42 billion, missing the consensus of $4.46 billion. Revenues were driven by strong volume growth across both segments, with pricing stabilizing due to inflation trends, especially in Education. FSS United States saw revenue growth...
Nestle's KitKat signs Formula 1 deal as CEO Freixe seeks broader appeal
Nestle's KitKat signs Formula 1 deal as CEO Freixe seeks broader appeal
Nov 11, 2024
LONDON (Reuters) - Nestle's KitKat brand has signed a global sponsorship deal with Formula 1 as new Chief Executive Laurent Freixe seeks to change the way the world's biggest food company markets its core, multi-billion-dollar brands. A senior executive told Reuters exclusively that the Formula 1 deal had been struck to cover the period between late 2025 and 2028, and...
Zai Lab, Argenx Receive Chinese Approval for Neuromuscular Drug Vyvgart Hytrulo
Zai Lab, Argenx Receive Chinese Approval for Neuromuscular Drug Vyvgart Hytrulo
Nov 11, 2024
08:03 AM EST, 11/11/2024 (MT Newswires) -- Zai Lab ( ZLAB ) and argenx (ARGX) said Monday that China's National Medical Products Administration has approved Vyvgart Hytrulo to treat chronic inflammatory demyelinating polyneuropathy, a neuromuscular disorder, in adult patients. The companies said the approval is supported by trial data from a subgroup analysis of Chinese participants which showed a 69%...
Copyright 2023-2026 - www.financetom.com All Rights Reserved